Des Moines Man Hospitalized as Dow Plunge Triggers Psychosomatic Crisis

DES MOINES, IA—Accountant Kevin Dern was admitted to Mercy General Hospital Tuesday following the Dow Jones Industrial Average's 670-point drop, complaining of debilitating pain behind his eyes. His wife, Brenda, stated Dern had been tracking his portfolio while working when he suddenly gripped his temples and muttered about 'resistance levels.'

'It began as a dull ache around 2:30 PM, coinciding with Cisco's decline,' Dern said from his hospital bed, a cold compress pressed to his forehead. 'By the closing bell, it felt like my prefrontal cortex was a scratchpad for a thousand day traders yelling sell orders.' Medical staff observed that Dern's pain spikes with market volatility; mentions of Nasdaq futures cause pupil dilation and monotone recitations of tech stock P/E ratios.

Dr. Arun Mehta, the attending neurologist, identified the condition as 'financial sympathetic resonance,' where the nervous system misinterprets economic data as physical trauma. 'We've documented stock-related stress before, but this is the first instance of a bad earnings report registering as a migraine,' Mehta said, adjusting an IV drip administering sedative and financial news. 'His MRI shows abnormal activity in the number-processing region. It's as if the ticker tape runs behind his eyelids.'

Dern's symptoms intensified Wednesday. Nurses reported him sitting upright to shout 'Technical rebound!' or 'Dead cat bounce!' before collapsing back, exhausted. By Thursday, as futures climbed modestly, his pain worsened. 'The uncertainty hurts most,' Dern whispered, squinting under fluorescent lights. 'Is it a recovery or a bull trap? My synapses can't take the whipsaw.'

Brenda Dern urged staff to remove clocks, as market open triggers blood pressure spikes. 'He asks for his phone to check pre-market activity,' she said. 'If Apple dips again, sedation may be necessary.' Administrators considered blackout curtains to block news headlines, a measure typically reserved for light-sensitive patients.

Economists from a nearby Federal Reserve branch requested to monitor Dern's vitals as a potential leading indicator of market sentiment. 'If his headache predicts sell-offs, we may have a biological volatility metric,' an analyst noted. The ethically questionable study was shelved. Dern remains in stable but uneasy condition, his health tethered to thirty large-cap stocks he doesn't own, a human barometer for national financial anxiety.